Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

, - 12:0NaN AM ET NaN/NaN/NaN mergers-and-acquisitions

Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.

AstraZeneca Enters Deal to Acquire Cell Therapy Firm EsoBiotec for Up to $1 Billion

MT Newswires - 44 minutes ago
Carlyle deal to buy Energean assets at risk of collapsing

Reuters - 58 minutes ago
Energean says regulatory approvals delay puts Carlyle deal at risk

Reuters - 3:21 AM ET 3/17/2025
AstraZeneca to buy EsoBiotec for up to $1 billion

Reuters - 3:20 AM ET 3/17/2025
Porsche SE says it is not considering sale of Volkswagen shares

Reuters - 5:06 AM ET 3/16/2025
Hennessy Advisors to Buy Two STF Management ETFs

MT Newswires - 4:56 PM ET 3/14/2025
BRIEF-Hennessy Advisors, Inc. To Acquire Stf Management Etfs And Welcome Portfolio Manager Jonathan Molchan

Reuters - 4:35 PM ET 3/14/2025
Sweden's Klarna discloses 24% revenue surge in much-awaited U.S. IPO filing

Reuters - 4:30 PM ET 3/14/2025

Related News